Jeil Pharmaceutical Co Ltd (271980) — Cash Flow Reinvestment Rate
Jeil Pharmaceutical Co Ltd (271980) has a Cash Flow Reinvestment Rate of 0.81x as of September 2025, reinvesting ₩10.66 Billion (capex ₩3.55 Billion plus investments ₩-7.11 Billion) from operating cash flow of ₩13.23 Billion. Check Jeil Pharmaceutical Co Ltd (271980) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jeil Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2018–2024)
Historical reinvestment intensity for Jeil Pharmaceutical Co Ltd across 4 annual periods. Explore Jeil Pharmaceutical Co Ltd (271980) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Jeil Pharmaceutical Co Ltd (2018–2024)
Year-by-year capital reinvestment analysis for Jeil Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 271980 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.47x | ₩7.93 Billion | ₩3.21 Billion | ₩6.61 Billion | ▲ +661.2% |
| 2021 | 0.32x | ₩6.19 Billion | ₩19.10 Billion | ₩5.34 Billion | ▲ +638.5% |
| 2019 | 0.04x | ₩1.27 Billion | ₩28.96 Billion | ₩1.09 Billion | ▼ -95.5% |
| 2018 | 0.96x | ₩20.69 Billion | ₩21.45 Billion | ₩10.29 Billion | — |